Published in JAMA on June 09, 2004
Early Detection of Cancers in Low Resource Countries | NCT01178736
Risk of ovarian cancer in women with symptoms in primary care: population based case-control study. BMJ (2009) 4.18
Predictive value of symptoms for early detection of ovarian cancer. J Natl Cancer Inst (2010) 3.42
Is late diagnosis of lung cancer inevitable? Interview study of patients' recollections of symptoms before diagnosis. Thorax (2005) 3.34
Cancer diagnosis in primary care. Br J Gen Pract (2010) 2.24
Identifying women with suspected ovarian cancer in primary care: derivation and validation of algorithm. BMJ (2011) 2.03
Symptoms and risk factors to identify women with suspected cancer in primary care: derivation and validation of an algorithm. Br J Gen Pract (2013) 1.82
Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer. Gynecol Oncol (2009) 1.77
Irritable bowel syndrome--the main recommendations. Dtsch Arztebl Int (2011) 1.56
Combining a symptoms index with CA 125 to improve detection of ovarian cancer. Cancer (2008) 1.53
Determining the date of diagnosis--is it a simple matter? The impact of different approaches to dating diagnosis on estimates of delayed care for ovarian cancer in UK primary care. BMC Med Res Methodol (2009) 1.41
Wnt signaling in ovarian tumorigenesis. Int J Gynecol Cancer (2007) 1.35
Identifying symptoms of ovarian cancer: a qualitative and quantitative study. BJOG (2008) 1.33
The interface of primary and oncology specialty care: from symptoms to diagnosis. J Natl Cancer Inst Monogr (2010) 1.26
Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials. J Natl Cancer Inst (2014) 1.24
A national initiative for women and healthcare providers: CDC's Inside Knowledge: Get the Facts About Gynecologic Cancer campaign. J Womens Health (Larchmt) (2011) 1.15
Irritable bowel syndrome: a clinical review. World J Gastroenterol (2014) 1.10
Crowdsourcing awareness: exploration of the ovarian cancer knowledge gap through Amazon Mechanical Turk. PLoS One (2014) 1.09
A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol (2009) 1.06
Gynecologic oncology patients' satisfaction and symptom severity during palliative chemotherapy. Health Qual Life Outcomes (2006) 1.00
Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav Immun (2012) 0.97
Intention to seek care for symptoms associated with gynecologic cancers, HealthStyles survey, 2008. Prev Chronic Dis (2011) 0.96
Sleep disturbance, distress, and quality of life in ovarian cancer patients during the first year after diagnosis. Cancer (2013) 0.95
Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells. J Ovarian Res (2010) 0.91
Identification of ovarian cancer symptoms in health insurance claims data. J Womens Health (Larchmt) (2010) 0.91
Symptoms of ovarian cancer--where to set the bar? JAMA (2004) 0.89
Experience of symptoms indicative of gynaecological cancers in UK women. Br J Cancer (2013) 0.89
Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability. Gynecol Oncol (2011) 0.88
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer. Oncogene (2014) 0.87
Prediagnostic symptoms of ovarian carcinoma: a case-control study. Gynecol Oncol (2009) 0.86
TRA-1-60(+), SSEA-4(+), Oct4A(+), Nanog(+) Clones of Pluripotent Stem Cells in the Embryonal Carcinomas of the Ovaries. J Stem Cell Res Ther (2012) 0.85
Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer. Gynecol Oncol (2013) 0.85
Validation of FACT/GOG-AD subscale for ovarian cancer-related abdominal discomfort: a Gynecologic Oncology Group study. Gynecol Oncol (2008) 0.83
Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients. BMC Cancer (2012) 0.82
Value of symptom-triggered diagnostic evaluation for ovarian cancer. Obstet Gynecol (2014) 0.82
Relationship between promoter methylation & tissue expression of MGMT gene in ovarian cancer. Indian J Med Res (2014) 0.81
Early detection of breast, cervical, ovarian and endometrial cancers in low resource countries: an integrated approach. Indian J Surg Oncol (2011) 0.81
Views of general practitioners on the role of CA125 in primary care to diagnose ovarian cancer. BMC Womens Health (2013) 0.80
The temporal stability of the Symptom Index among women at high-risk for ovarian cancer. Gynecol Oncol (2009) 0.79
Clinico-histopathological analysis of neoplastic and non-neoplastic lesions of the ovary: a 3-year prospective study in dhule, north maharashtra, India. J Clin Diagn Res (2014) 0.79
Accuracy of 64-multidetector computed tomography in diagnosis of adnexal tumors. J Ovarian Res (2011) 0.79
Symptoms and risk factors of ovarian cancer: a survey in primary care. ISRN Obstet Gynecol (2012) 0.78
Impact of a computer-based diagnostic decision support tool on the differential diagnoses of medicine residents. J Grad Med Educ (2012) 0.77
Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records. BMC Fam Pract (2014) 0.77
Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses. BMC Cancer (2013) 0.76
Diagnostic utility of PAX8 in differentiation of mullerian from non-mullerian tumors. Adv Biomed Res (2014) 0.76
A terrible beauty: a physician's story of ovarian cancer. Can Fam Physician (2007) 0.75
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian Cancer. J Womens Health (Larchmt) (2016) 0.75
Estimating the Prevalence of Ovarian Cancer Symptoms in Women Aged 50 Years or Older: Problems and Possibilities. Am J Epidemiol (2016) 0.75
Initial medical attention on patients with early-stage non-small cell lung cancer. PLoS One (2012) 0.75
In reply: A large-scale study on the role of ovarian symptom index is necessary. J Gynecol Oncol (2010) 0.75
Effects of Demographics and OTC Analgesics on Ovarian Cancer Symptoms. J Nurse Pract (2013) 0.75
Genetic variants in matrix metalloproteinase genes as disposition factors for ovarian cancer risk, survival, and clinical outcome. Mol Carcinog (2013) 0.75
Recurrence patterns after extended treatment with bevacizumab for ovarian, fallopian tube, and primary peritoneal cancers. Gynecol Oncol (2013) 0.75
Modified Goff Symptom Index: Simple triage tool for ovarian malignancy. Sultan Qaboos Univ Med J (2015) 0.75
"A peculiar time in my life": making sense of illness and recovery with gynaecological cancer. Int J Qual Stud Health Well-being (2017) 0.75
Development of an ovarian cancer symptom index: possibilities for earlier detection. Cancer (2007) 4.76
An evaluation of cervical cancer in women age sixty and over. Gynecol Oncol (2008) 1.43
Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol (2006) 1.37
Surgical skills assessment: a blinded examination of obstetrics and gynecology residents. Am J Obstet Gynecol (2002) 1.14
Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study. Cancer (2011) 1.11
Incidence and management of abdominal sacrocolpopexy mesh erosions. Am J Obstet Gynecol (2005) 1.07
High complication rate identified in sacrocolpopexy patients attributed to silicone mesh. Urology (2005) 0.98
A six-year study of surgical teaching and skills evaluation for obstetric/gynecologic residents in porcine and inanimate surgical models. Am J Obstet Gynecol (2005) 0.96
Objective structured assessment of technical skills for episiotomy repair. Am J Obstet Gynecol (2003) 0.91
Can mentors prevent and reduce burnout in new chairs of departments of obstetrics and gynecology: results from a prospective, randomized pilot study. Am J Obstet Gynecol (2008) 0.82
Evaluation of p27 in preinvasive and invasive malignancies of the cervix. Gynecol Oncol (2003) 0.79
Interleukin-18 in the plasma of women with preeclampsia. Am J Obstet Gynecol (2003) 0.76
Use of a postpartum hemorrhage simulator for instruction and evaluation of residents. J Grad Med Educ (2009) 0.75
We need a new paradigm in gynecologic cancer care: SGO proposes solutions for delivery, quality and reimbursement policies. Gynecol Oncol (2013) 0.75